Moreover, aberrant expression of UBE2I has been implicated in the development and progression of various human cancers, including breast cancer, gliomas, lung cancer, head and neck squamous cell carcinoma, osteosarcoma, and hepatocellular carcinoma43. The gene discussed is UBE2I; the disease is glioma.